Clinical Trial Update: SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update shows completion of a Phase 1 study of the SF2a-TT15 Conjugate Vaccine in healthy adult volunteers. The study targets Shigellosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacillary Dysentery
• Shigellosis

Drugs mentioned

• SF2a-TT15 Conjugate Vaccine

Snippet

Sponsor: Institut Pasteur | Conditions: Shigellosis, Bacillary Dysentery | Phase 1 | Status: COMPLETED